Status:
COMPLETED
Safety and Efficacy of the CryoCor™ Cardiac Cryoablation System for the Treatment of Atrial Flutter
Lead Sponsor:
Boston Scientific Corporation
Conditions:
Atrial Flutter
Eligibility:
All Genders
18-75 years
Phase:
PHASE3
Brief Summary
The purpose of this study is to evaluate the safety and efficacy of right atrial intra-cardiac lesions created by transvenous catheter cryoablation in patients with atrial flutter.
Detailed Description
Catheter ablation of arrhythmias has become an accepted alternative to pharmacologic therapy. Cryoablation is a newer alternative to radiofrequency ablations. This study expands the prior pilot experi...
Eligibility Criteria
Inclusion
- Symptomatic atrial flutter
Exclusion
- Prior ablation
- Contraindication to intervention
- Poor general health
Key Trial Info
Start Date :
January 1 2004
Trial Type :
INTERVENTIONAL
End Date :
June 1 2005
Estimated Enrollment :
160 Patients enrolled
Trial Details
Trial ID
NCT00113178
Start Date
January 1 2004
End Date
June 1 2005
Last Update
February 24 2011
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.